{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:18:08Z","timestamp":1791613088846,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pcad.2020.01.005","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:19:28Z","timestamp":1580440768000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Physical activity and exercise to improve cardiovascular health for adults living with HIV"],"prefix":"10.1016","volume":"63","author":[{"given":"Cemal","family":"Ozemek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Erlandson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2020.01.005_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","author":"Antiretroviral Therapy Cohort C","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjcard.2015.10.030","article-title":"Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013","volume":"117","author":"Feinstein","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","article-title":"Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study","volume":"71","author":"Legarth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.pcad.2020.01.005_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11904-016-0334-8","article-title":"Frailty in HIV: epidemiology, biology, measurement, interventions, and research needs","volume":"13","author":"Piggott","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.pcad.2020.01.005_bb0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.pcad.2020.01.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007107","article-title":"Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study","volume":"6","author":"Ladapo","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2020.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jacc.2017.08.012","article-title":"Cardiopulmonary exercise testing: what is its value?","volume":"70","author":"Guazzi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0040","unstructured":"Agenerase (amprenavir) [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2005."},{"key":"10.1016\/j.pcad.2020.01.005_bb0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00002030-200205030-00003","article-title":"Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels","volume":"16","author":"R\u00f8ge","year":"2002","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.pcad.2020.01.005_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/apc.2008.0142","article-title":"Cardiac diastolic dysfunction is prevalent in HIV-infected patients","volume":"23","author":"Nayak","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.pcad.2020.01.005_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/apc.2019.0149","article-title":"Association of diastolic dysfunction with reduced cardiorespiratory fitness in adults living with HIV","volume":"33","author":"Oursler","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.pcad.2020.01.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw032","article-title":"START or SMART? Timing of antiretroviral therapy initiation and cardiovascular risk for people with human immunodeficiency virus infection","volume":"3","author":"Siedner","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.pcad.2020.01.005_bb0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14740338.2019.1644317","article-title":"Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment","volume":"18","author":"Lagathu","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pcad.2020.01.005_bb0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/cid\/cix178","article-title":"Practical review of recognition and management of obesity and lipohypertrophy in human immunodeficiency virus infection","volume":"64","author":"Lake","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11904-016-0298-8","article-title":"Fat matters: understanding the role of adipose tissue in health in HIV infection","volume":"13","author":"Erlandson","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.pcad.2020.01.005_bb0085","first-page":"37","article-title":"Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat","volume":"17","author":"Renjifo","year":"2015","journal-title":"AIDS Rev"},{"key":"10.1016\/j.pcad.2020.01.005_bb0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure","volume":"72","author":"Alvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0095","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/S2352-3018(18)30043-2","article-title":"Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study","volume":"5","author":"Ryom","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.pcad.2020.01.005_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.aids.0000199825.34241.49","article-title":"Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness","volume":"20","author":"Bangsberg","year":"2006","journal-title":"Aids"},{"issue":"suppl 1","key":"10.1016\/j.pcad.2020.01.005_bb0105","article-title":"Protease inhibitor-based regimens for HIV therapy: safety and efficacy","volume":"45","author":"Walmsley","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.pcad.2020.01.005_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cid\/cir324","article-title":"Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG study A5224s","volume":"53","author":"McComsey","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/QAD.0000000000000266","article-title":"Impact of randomized antiretroviral therapy initiation on glucose metabolism","volume":"28","author":"Erlandson","year":"2014","journal-title":"Aids"},{"key":"10.1016\/j.pcad.2020.01.005_bb0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M14-1084","article-title":"Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial","volume":"161","author":"Lennox","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2020.01.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw174","article-title":"Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s","volume":"3","author":"Dirajlal-Fargo","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0130","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/QAD.0000000000000762","article-title":"A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness","volume":"29","author":"Stein","year":"2015","journal-title":"Aids"},{"key":"10.1016\/j.pcad.2020.01.005_bb0135","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/QAI.0000000000002071","article-title":"Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the United States","volume":"81","author":"Crane","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.pcad.2020.01.005_bb0140","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12879-017-2808-8","article-title":"Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study","volume":"17","author":"Dorjee","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0000000000000881","article-title":"Use of abacavir and risk of cardiovascular disease among HIV-infected individuals","volume":"71","author":"Marcus","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.pcad.2020.01.005_bb0150","article-title":"Antiretroviral drugs associated with subclinical coronary artery disease in the Swiss HIV Cohort study","author":"Kovari","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0155","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/QAD.0b013e328347fa16","article-title":"Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons","volume":"25","author":"Choi","year":"2011","journal-title":"Aids"},{"key":"10.1016\/j.pcad.2020.01.005_bb0160","first-page":"9","article-title":"Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis","volume":"e025874","author":"Eyawo","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcad.2020.01.005_bb0165","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/QAD.0000000000002350","article-title":"Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back","volume":"33","author":"Milinkovic","year":"2019","journal-title":"Aids"},{"key":"10.1016\/j.pcad.2020.01.005_bb0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/apc.2019.0236","article-title":"Switching from tenofovir disoproxil fumarate to tenofovir alafenamide significantly worsens the lipid profile in a real-world setting","volume":"33","author":"Kauppinen","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.pcad.2020.01.005_bb0175","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","author":"Sax","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s15010-018-1227-0","article-title":"A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015\u20132017","volume":"47","author":"Gomez","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.pcad.2020.01.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz112","article-title":"Maraviroc intensification modulates atherosclerotic progression in HIV-suppressed patients at high cardiovascular risk. A randomized, crossover pilot study","volume":"6","author":"Francisci","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3851\/IMP3091","article-title":"Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity","volume":"22","author":"Funderburg","year":"2017","journal-title":"Antivir Ther"},{"key":"10.1016\/j.pcad.2020.01.005_bb0195","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/cid\/civ193","article-title":"Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257","volume":"60","author":"Ofotokun","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0200","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/cid\/cix467","article-title":"Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease","volume":"65","author":"Macias","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/23744235.2019.1629008","article-title":"Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease","volume":"51","author":"Calza","year":"2019","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.pcad.2020.01.005_bb0210","article-title":"Weight gain associated with integrase stand transfer inhibitor use in women","author":"Kerchberger","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMoa1904340","article-title":"Dolutegravir-based or low-dose efavirenz-based regimen for the treatment of HIV-1","volume":"381","author":"Kouanfack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2020.01.005_bb0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2020.01.005_bb0225","article-title":"Greater weight gain in treatment naive persons starting dolutegravir-based antiretroviral therapy","author":"Bourgi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.pcad.2020.01.005_bb0235","article-title":"Do integrase inhibitors cause weight gain?","author":"Wood","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2055-6640(20)30277-6","article-title":"Are new antiretroviral treatments increasing the risks of clinical obesity?","volume":"5","author":"Hill","year":"2019","journal-title":"J Virus Erad"},{"key":"10.1016\/j.pcad.2020.01.005_bb0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ecl.2014.05.004","article-title":"From wasting to obesity, changes in nutritional concerns in HIV\/AIDS","volume":"43","author":"Mankal","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pcad.2020.01.005_bb0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.17925\/EE.2014.10.01.18","article-title":"Exercise is medicine - the importance of physical activity, exercise training, cardiorespiratory fitness and obesity in the prevention and treatment of type 2 diabetes","volume":"10","author":"Lavie","year":"2014","journal-title":"Eur Endocrinol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2017.06.002","article-title":"Taking physical activity, exercise, and fitness to a higher level","volume":"60","author":"Wisloff","year":"2017","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCRESAHA.118.312669","article-title":"Sedentary behavior, exercise, and cardiovascular health","volume":"124","author":"Lavie","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2020.01.005_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01641","article-title":"Influence of physical exercise on advanced glycation end products levels in patients living with the human immunodeficiency virus","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0270","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1080\/09638288.2017.1306587","article-title":"Physical activity correlates in people living with HIV\/AIDS: a systematic review of 45 studies","volume":"40","author":"Vancampfort","year":"2018","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.pcad.2020.01.005_bb0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/JES.0b013e3181aa65fc","article-title":"High-intensity interval training to maximize cardiac benefits of exercise training?","volume":"37","author":"Wisl\u00f8ff","year":"2009","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.pcad.2020.01.005_bb0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1055-3290(06)60199-4","article-title":"Effectiveness of a home-based exercise intervention for HIV-infected adults: a randomized trial","volume":"13","author":"Baigis","year":"2002","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1016\/j.pcad.2020.01.005_bb0285","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bjsports-2013-092576","article-title":"High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis","volume":"48","author":"Weston","year":"2014","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.pcad.2020.01.005_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00005768-199801000-00003","article-title":"The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients","volume":"30","author":"Stringer","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2020.01.005_bb0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00002030-200104130-00004","article-title":"Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults","volume":"15","author":"Smith","year":"2001","journal-title":"Aids"},{"key":"10.1016\/j.pcad.2020.01.005_bb0300","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12879-016-1478-2","article-title":"Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane collaboration protocol","volume":"16","author":"O\u2019Brien","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/aid.2007.0023","article-title":"Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: a randomized controlled trial","volume":"24","author":"Mutimura","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.pcad.2020.01.005_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198855","article-title":"A pilot randomized aerobic exercise trial in older HIV-infected men: insights into strategies for successful aging with HIV","volume":"13","author":"Oursler","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pcad.2020.01.005_bb0315","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/17461391.2016.1167962","article-title":"Non-linear resistance training reduces inflammatory biomarkers in persons living with HIV: a randomized controlled trial","volume":"16","author":"Zanetti","year":"2016","journal-title":"Eur J Sport Sci"},{"key":"10.1016\/j.pcad.2020.01.005_bb0320","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.4081\/idr.2019.7925","article-title":"Strength training improves body composition, muscle strength and increases CD4+ T lymphocyte levels in people living with HIV\/AIDS","volume":"11","author":"de Brito-Neto","year":"2019","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.pcad.2020.01.005_bb0325","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1123\/jpah.2015-0540","article-title":"Nonlinear resistance training enhances the lipid profile and reduces inflammation marker in people living with HIV: a randomized clinical trial","volume":"13","author":"Zanetti","year":"2016","journal-title":"J Phys Act Health"},{"key":"10.1016\/j.pcad.2020.01.005_bb0330","doi-asserted-by":"crossref","first-page":"678","DOI":"10.23736\/S0022-4707.16.06294-0","article-title":"Does nonlinear resistance training reduce metabolic syndrome in people living with HIV? A randomized clinical trial","volume":"57","author":"Zanetti","year":"2017","journal-title":"J Sports Med Phys Fitness"},{"key":"10.1016\/j.pcad.2020.01.005_bb0335","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1519\/JSC.0000000000002289","article-title":"Adding resistance training to the standard of care for inpatient substance abuse treatment in men with human immunodeficiency virus improves skeletal muscle health without altering cytokine concentrations","volume":"32","author":"Vingren","year":"2018","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.pcad.2020.01.005_bb0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S1807-59322011000200014","article-title":"Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls","volume":"66","author":"Souza","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.pcad.2020.01.005_bb0345","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1519\/JSC.0000000000002394","article-title":"Effect of 8 weeks of hospital-based resistance training program on TCD4+ cell count and anthropometric characteristic of patients with HIV in Tehran, Iran: a randomized controlled trial","volume":"33","author":"Ghayomzadeh","year":"2019","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.pcad.2020.01.005_bb0350","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.23736\/S0022-4707.16.06357-X","article-title":"Lymphocyte CD4+ cell count, strength improvements, heart rate and body composition of HIV-positive patients during a 3-month strength training program","volume":"57","author":"Bessa","year":"2017","journal-title":"J Sports Med Phys Fitness"},{"key":"10.1016\/j.pcad.2020.01.005_bb0355","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1519\/JSC.0000000000001001","article-title":"Impact of strength training on bone mineral density in patients infected with HIV exhibiting lipodystrophy","volume":"29","author":"Santos","year":"2015","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.pcad.2020.01.005_bb0360","first-page":"1","article-title":"Acute effects of resistance-exercise intensity in depressed Black\/African Americans living with HIV: a randomized pilot study","author":"Nosrat","year":"2019","journal-title":"J Sport Exerc Psychol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0365","doi-asserted-by":"crossref","first-page":"688","DOI":"10.12965\/jer.1836212.106","article-title":"Blood pressure responses after resistance exercise session in women living with human immunodeficiency virus\/acquired immunodeficiency syndrome","volume":"14","author":"Domingues","year":"2018","journal-title":"J Exerc Rehabil"},{"key":"10.1016\/j.pcad.2020.01.005_bb0370","series-title":"International Workshop HIV\/Aging. New York City, New York","article-title":"Blunted increase in muscle mass after exercise training in people aging with HIV","author":"Jankowski","year":"2019"},{"key":"10.1016\/j.pcad.2020.01.005_bb0375","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1249\/MSS.0000000000002120","article-title":"Effects of exercise training and statin use in people living with human immunodeficiency virus with dyslipidemia","volume":"52","author":"Zanetti","year":"2020","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2020.01.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005263","article-title":"Physical activity guidelines for Americans from the US Department of Health and Human Services","volume":"11","author":"Piercy","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.pcad.2020.01.005_bb0385","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pcad.2019.02.004","article-title":"Global physical activity levels - need for intervention","volume":"62","author":"Ozemek","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2017.01.004","article-title":"Epidemiology of physical activity and exercise training in the United States","volume":"60","author":"Katzmarzyk","year":"2017","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.005_bb0395","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/09638288.2016.1260645","article-title":"Global physical activity levels among people living with HIV: a systematic review and meta-analysis","volume":"40","author":"Vancampfort","year":"2018","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.pcad.2020.01.005_bb0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jana.2009.11.003","article-title":"The international physical activity questionnaire overestimates moderate and vigorous physical activity in HIV-infected individuals compared with accelerometry","volume":"21","author":"Fillipas","year":"2010","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1016\/j.pcad.2020.01.005_bb0405","series-title":"Early release of selected estimates based on data from the January\u2013September 2017 National Health Interview Survey","author":"Schiller","year":"2018"},{"key":"10.1016\/j.pcad.2020.01.005_bb0410","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjmed.2016.05.005","article-title":"The call for a physical activity vital sign in clinical practice","volume":"129","author":"Sallis","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2020.01.005_bb0415","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1249\/MSS.0000000000000565","article-title":"Accelerometer validation of questionnaires used in clinical settings to assess MVPA","volume":"47","author":"Fitzgerald","year":"2015","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2020.01.005_bb0420","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jana.2018.05.005","article-title":"Association between the 6-minute walk test distance and peak cardiorespiratory fitness among people living with HIV varies by fitness level","volume":"29","author":"Oliveira","year":"2018","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1016\/j.pcad.2020.01.005_bb0425","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1751-7133.2010.00151.x","article-title":"The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure","volume":"16","author":"Boxer","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.pcad.2020.01.005_bb0430","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/HCO.0000000000000406","article-title":"Nonpharmacologic management of hypertension: a multidisciplinary approach","volume":"32","author":"Ozemek","year":"2017","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.pcad.2020.01.005_bb0435","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJM199511023331806","article-title":"A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure","volume":"333","author":"Rich","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcad.2020.01.005_bb0440","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1249\/MSS.0000000000002125","article-title":"A mobile application for exercise intervention in people living with HIV","volume":"52","author":"Bonato","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2020.01.005_bb0445","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11904-019-00467-0","article-title":"Contemporary lifestyle modification interventions to improve metabolic comorbidities in HIV","volume":"16","author":"Fitch","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.pcad.2020.01.005_bb0450","article-title":"Behavioral weight loss: a promising treatment for obesity in adults with HIV","author":"Panza","year":"2019","journal-title":"AIDS Behav"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306202030027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306202030027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:19:00Z","timestamp":1758500340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003306202030027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S003306202030027X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.005","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical activity and exercise to improve cardiovascular health for adults living with HIV","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}